Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Direct oral anticoagulants for cancer-associated...
Journal article

Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis

Abstract

Direct oral anticoagulants (DOACs) are an emerging treatment option for patients with cancer and acute venous thromboembolism (VTE), but studies have reported inconsistent results. This systematic review and meta-analysis compared the efficacy and safety of DOACs and low-molecular-weight heparins (LMWHs) in these patients. MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, and conference proceedings were searched to identify …

Authors

Mulder FI; Bosch FTM; Young AM; Marshall A; McBane RD; Zemla TJ; Carrier M; Kamphuisen PW; Bossuyt PMM; Büller HR

Journal

Blood, Vol. 136, No. 12, pp. 1433–1441

Publisher

American Society of Hematology

Publication Date

September 17, 2020

DOI

10.1182/blood.2020005819

ISSN

0006-4971